ZA943317B - Stable quinolone and napthyridine premix formulations - Google Patents

Stable quinolone and napthyridine premix formulations

Info

Publication number
ZA943317B
ZA943317B ZA943317A ZA943317A ZA943317B ZA 943317 B ZA943317 B ZA 943317B ZA 943317 A ZA943317 A ZA 943317A ZA 943317 A ZA943317 A ZA 943317A ZA 943317 B ZA943317 B ZA 943317B
Authority
ZA
South Africa
Prior art keywords
napthyridine
quinolone
stable
premix formulations
premix
Prior art date
Application number
ZA943317A
Other languages
English (en)
Inventor
Pramod K Gupta
Laman A Al-Razzak
Patricia L Ludwig
Nishith V Gandhi
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA943317B publication Critical patent/ZA943317B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA943317A 1993-05-15 1994-05-13 Stable quinolone and napthyridine premix formulations ZA943317B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6244793A 1993-05-15 1993-05-15

Publications (1)

Publication Number Publication Date
ZA943317B true ZA943317B (en) 1995-01-23

Family

ID=22042549

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943317A ZA943317B (en) 1993-05-15 1994-05-13 Stable quinolone and napthyridine premix formulations

Country Status (4)

Country Link
AU (1) AU6832394A (xx)
IL (1) IL109626A0 (xx)
WO (1) WO1994026110A1 (xx)
ZA (1) ZA943317B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
GR1008168B (el) * 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3831514A1 (de) * 1988-09-16 1990-03-22 Bayer Ag Ph-neutrale waessrige loesungen von chinoloncarbonsaeuren
US5225413A (en) * 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids

Also Published As

Publication number Publication date
IL109626A0 (en) 1994-08-26
WO1994026110A1 (en) 1994-11-24
AU6832394A (en) 1994-12-12

Similar Documents

Publication Publication Date Title
AU4939693A (en) Combination pin pad and terminal
GB9209787D0 (en) Jacks and dentists or other chairs
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
AP9901623A0 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
GB9525977D0 (en) Perfluoroelastomeric compositions and methods
IL111978A0 (en) Dry-compressed paroxetine formulations and their preparation
IL115891A0 (en) Hemorrhoidial compositions and their use
ZA9410235B (en) Slow-release insect-repellent formulations and uses
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
IL104618A0 (en) Plug and socket system
ZA924491B (en) Compositions and use thereof
ZA943317B (en) Stable quinolone and napthyridine premix formulations
AU1106392A (en) Composition and use
AU4419293A (en) Pharmaceutical compositions having antiaggregant and vasodilating activities
IL110347A0 (en) Azine derivatives and their preparation
ZA9711047B (en) Formulation and use.
ZA935076B (en) Quinoline and naphthyridine prodrugs
GB9722958D0 (en) Galenical formulations
GB9501907D0 (en) Allatostatins and their use
GB9306456D0 (en) Composition and use
GB9107871D0 (en) Ball and socket joint
AU2219997A (en) Polysorbate-containing compositions and their use against helicobacter
GB9408859D0 (en) Composition and use
ZA948902B (en) P-Hydroxyaniline derivatives their preparation and their use
GB9401132D0 (en) Enzyme formulation and its use